changing from semaglutide to tirzepatide Switching dose conversion Switching from semaglutide to tirzepatide

Consistent Supply: Convenient tray packaging (25 vials per tray) for high-volume environments

While no GLP-1 medication currently carries FDA approval specifically for fatty liver disease, accumulating evidence supports their therapeutic potential through weight loss, improved insulin sensitivity, and reduced systemic inflammation

For patients with confirmed B12 deficiencywhether due to dietary restrictions, absorption issues, or conditions like pernicious anemiaB12 injections can be an effective way to quickly restore healthy levels

OZEMPIC (semaglutide) tablets, for oral use

Inner thigh lifts are particularly popular among GLP-1 patients who experience significant skin laxity that causes discomfort during walking or exercise

Get the best of both facials with Hydrafacial's deeply exfoliating vacuum vortex and the instant anti-aging and hydrating glow of the Glo2Facial